The Intergenerational Effects of Intermarriage

Journal of International Migration and Integration / Revue de l integration et de la migration internationale ◽

10.1007/s12134-019-00745-1 ◽

2020 ◽

Author(s):

Anna Tegunimataka

Keyword(s):

Second Generation ◽

Unobserved Heterogeneity ◽

Country Of Origin ◽

Educational Performance ◽

Human Capital Formation ◽

Long Term Outcomes ◽

Migration Literature ◽

Second Generation Immigrants ◽

Family Level

AbstractThis study closely examines long-term outcomes of intermarriage in Denmark in terms of children’s educational performance, studying grades from final examinations. The study uses rich register data, where families are linked across generations, and contributes to the migration literature by providing new insights into the human capital formation in inter-ethnic families. The outcomes of children of intermarriage are very much in line with the outcomes of children with two native-born Danish parents. Compared to second-generation immigrants, children of intermarriage perform substantially better, and these differences remain even when school and family-level confounders are taken into account. Moreover, this paper explores the heterogeneous character of the 2.5 generation in Denmark and studies the importance of parental country of origin. Parental country of origin is of significance for the educational performance of children from intermarriage in Denmark, as the performance of children with a non-native parent originating from countries of Africa, Asia, and Latin America is closer to that of second-generation immigrants, rather than natives. This association remains (for certain groups) when controlling for unobserved heterogeneity at the school and family level.

Download Full-text

Long term outcomes of ultrathin versus standard thickness second‐generation drug eluting stents: Meta‐analysis of randomized trials

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.29866 ◽

2021 ◽

Author(s):

Yasin Hussain ◽

Samantha Gaston ◽

Johnathan Kluger ◽

Tayyab Shah ◽

Yiping Yang ◽

...

Keyword(s):

Randomized Trials ◽

Second Generation ◽

Meta Analysis ◽

Drug Eluting Stents ◽

Long Term Outcomes ◽

Drug Eluting

Download Full-text

Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: Retrospective comparison of first generation and second generation antipsychotics

Schizophrenia Research ◽

10.1016/j.schres.2006.06.038 ◽

2006 ◽

Vol 88 (1-3) ◽

pp. 127-134 ◽

Cited By ~ 14

Author(s):

Leonard White ◽

Joseph I. Friedman ◽

Christopher R. Bowie ◽

Martin Evers ◽

Philip D. Harvey ◽

...

Keyword(s):

First Generation ◽

Geriatric Patients ◽

Second Generation ◽

Long Term Outcomes ◽

Retrospective Comparison ◽

Second Generation Antipsychotics ◽

Hospitalized Geriatric Patients

Download Full-text

Long‐term outcomes of pulmonary vein isolation using second‐generation cryoballoon during atrial fibrillation ablation

Pacing and Clinical Electrophysiology ◽

10.1111/pace.13721 ◽

2019 ◽

Vol 42 (7) ◽

pp. 910-921 ◽

Cited By ~ 4

Author(s):

Ugur Canpolat ◽

Duygu Kocyigit ◽

Muhammed Ulvi Yalcin ◽

Cem Coteli ◽

Yusuf Ziya Sener ◽

...

Keyword(s):

Atrial Fibrillation ◽

Pulmonary Vein ◽

Pulmonary Vein Isolation ◽

Second Generation ◽

Atrial Fibrillation Ablation ◽

Long Term Outcomes

Download Full-text

Effects of Country of Origin and Wave of Immigration on Prevalence of Schizophrenia Among First and Second-Generation Immigrants: A 30-Year Retrospective Study

Biological Psychiatry ◽

10.1016/j.biopsych.2020.02.994 ◽

2020 ◽

Vol 87 (9) ◽

pp. S388-S389

Author(s):

Gilad Eger ◽

Yonatan Reuven ◽

Jacob Dreiher ◽

Pesach Shvartzman ◽

Mark Weiser ◽

...

Keyword(s):

Retrospective Study ◽

Second Generation ◽

Country Of Origin ◽

Second Generation Immigrants ◽

First And Second Generation

Download Full-text

Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial Infarction

JACC Cardiovascular Interventions ◽

10.1016/j.jcin.2019.08.020 ◽

2020 ◽

Vol 13 (1) ◽

pp. 97-111 ◽

Cited By ~ 1

Author(s):

Jeong Cheon Choe ◽

Kwang Soo Cha ◽

Jeong Gyu Lee ◽

Jinmi Kim ◽

Ji Yeon Shin ◽

...

Keyword(s):

Myocardial Infarction ◽

Second Generation ◽

Drug Eluting Stent ◽

Long Term Outcomes ◽

Durable Polymer ◽

Drug Eluting

Download Full-text

P1920Long-term outcomes of pulmonary vein isolation using second-generation cryoballoon during atrial fibrillation ablation: A single-center large-scale study

European Heart Journal ◽

10.1093/eurheartj/ehz748.0667 ◽

2019 ◽

Vol 40 (Supplement_1) ◽

Author(s):

U Canpolat ◽

D Kocyigit ◽

M U Yalcin ◽

C Coteli ◽

Y Z Sener ◽

...

Keyword(s):

Pulmonary Vein ◽

Pulmonary Vein Isolation ◽

Large Scale ◽

Second Generation ◽

Significant Proportion ◽

Complication Rates ◽

Long Term Outcomes ◽

Free Survival

Abstract Background Currently available second-generation cryoballoon (CB2) is accepted as an effective and safe tool for pulmonary vein isolation (PVI). Although much more data exists about 1-year outcomes of CB2 ablation, data on long-term outcomes are scarce. Objective: We aimed to assess the long-term outcomes of PVI using CB2 in a large-scale symptomatic AF population at our tertiary referral center. Methods In this non-randomized prospective observational study, a total of 486 patients with paroxysmal (71%) or persistent (29%) AF who underwent index PVI using CB2 at our hospital between January 2013 and June 2017 were enrolled. Atrial tachyarrhythmia (ATa) free survival was defined as absence of AF, atrial flutter or atrial tachycardia recurrence >30 s following 3-months blanking period. Predictors of recurrence were evaluated by univariate and multivariate Cox proportional hazards regression models. Results Acute procedural success rate was 99.8% (1898/1902 PVs). Mean procedural and fluoroscopy time were 64.9±9.2 and 12.1±2.6, respectively. At median 39 (IQR: 26–56) months follow-up, ATa free survival was 78.6% after a single procedure (280/345 [81.2%] for paroxysmal AF vs 102/141 [72.3%] for persistent AF, p=0.019) and 84.4% after a mean 1.48±0.42 ablations.Cox regression analysis showed that left atrium diameter, duration of AF history and early ATa recurrence were found as the independent predictors of late recurrence. PNP was observed in 17 (3.5%) patients. Figure 1 Conclusions Second-generation CB based PVI is effective to maintain sinus rhythm in a significant proportion of paroxysmal and early persistent AF patients with an acceptable complication rates at long-term follow-up.

Download Full-text

BCR/ABL Transcript At 3 Months Predicts Long-Term Outcomes Following Second Generation Tyrosine Kinase Inhibitor Therapy in the Patients with CML in Chronic Phase Who Failed Imatinib.

Blood ◽

10.1182/blood.v120.21.2777.2777 ◽

2012 ◽

Vol 120 (21) ◽

pp. 2777-2777

Author(s):

Dennis Dong Hwan Kim ◽

Hong Gi Lee ◽

Suzanne Kamel-Reid ◽

Jeffrey H. Lipton

Keyword(s):

Tyrosine Kinase ◽

Treatment Failure ◽

Tyrosine Kinase Inhibitor ◽

Second Generation ◽

Kinase Inhibitor ◽

Chronic Phase ◽

Transcript Level ◽

Molecular Response ◽

Long Term Outcomes

Abstract Abstract 2777 Background: The BCR/ABL transcript level at 3 months can predict long-term outcomes following frontline therapy with Imatinib or Dasatinib in chronic myeloid leukemia (CML) patients. However, data is lacking with second generation tyrosine kinase inhibitor (2GTKI) therapy after Imatinib failure. Methods: A total of 112 patients with CML in chronic phase (CP) receiving 2GTKI after Imatinib failure were reviewed. Treatment outcomes including complete cytogenetic (CCyR), major molecular (MMR) and molecular response 4.5 (MR4.5), treatment failure, progression-free (PFS) and overall survival (OS) were compared according to BCR/ABL transcript levels at 3 or 6 months, divided into <1%IS, 1–10%IS and °Ã10%IS. Results: Using cut off of 1%IS and 10%IS BCR/ABL transcript level, 70 patients (65%) showed <1%IS of BCR/ABL transcript level at 3 months, 16 patients (15%) between 1 and 10%IS, and 21 patients (20%), °Ã10%IS at 3 months. BCR/ABL transcript level at 3 months showed better correlation with OS (p<0.001) than that at 6 months (p=0.147). Better OS was also observed in the patients achieving <1%IS (100%) and 1–10%IS (100%) than those with °Ã10%IS at 3 months (70.6%, p<0.001). Those with <1%IS exhibited the best CCyR (100% at 12 months), MMR (93.1±3.2% at 18 months) and MR4.5 (80.2±6.3% at 3 years); those with 1–10%IS, intermediate (56.4±15.5% CCyR at 12 months; 22.1±14.1% MMR at 18 months; 10.0±9.5% MR4.5 at 3 years); and those with °Ã10%IS, the lowest CCyR (16.7±11.2% at 12 months), MMR (6.2±6.1% at 18 months) and MR4.5 rates (0%). Especially, in the subgroup of Imatinib resistant patients (n=59), none of them achieved MR4.5 if BCR/ABL transcript level is above 1% at 3 months (i.e. those with 1–10%IS or °Ã10%IS). Multivariate analysis confirmed strong correlation of BCR/ABL transcript level at 3 months with CCyR (HR 0.019), MMR (HR 0.047), MR4.5 (HR 0.057), treatment failure (HR 12.264), PFS (HR 7.754) and OS (HR 15.115). The group with <1%IS at 3 months maintained significantly lower BCR/ABL transcript level compared to other 2 groups. Conclusion: The BCR/ABL transcript level at 3 months is the most relevant surrogate for outcomes following 2GTKI therapy after Imatinib failure. Disclosures: No relevant conflicts of interest to declare.

Download Full-text